Old and New Drug Development Paradigms: Cytel Infographic

Posted by Esha Senchaudhuri

Jan 16, 2015 11:05:00 AM

Adaptive designs are thought to be the new paradigm in drug development, allowing statisticians and trial designers to create trials that give the best probability of success for each drug, while diminishing clinical development costs. Over the next weeks we'll be releasing 2-3 infographics on adaptive trials and clinical development.  

Old and New Drug Development Paradigms

This infographic demonstrates three critical differences between old and new drug development paradigms: the budget allocations, the decision-making oportunities, and the resulting decrease in the length of a highly powered trial.

For more information read:

Visit Cytel Consulting Contact our Consultants

Cytel-Whitepaper_Nov-2014-infographic-1

 

The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.

 

Posts by Topic

see all

Recent Posts